MGB Biopharma Presents at INV€$TIVAL SHOWCASE 2019

December 3, 2019

Glasgow, Scotland, 3^rd December 2019 – Raymond Spencer, CFO of MGB Biopharma Ltd. presented at INV€$STIVAL SHOWCASE in London on 19^th November 2019.

Please see video of full presentation below:

News

MGB Biopharma Announces Successful Outcome from Phase II Clinical Study with MGB-BP-3 – a Potential New Gold Standard, First-Line Treatment for Clostridium difficile Infection (CDI)

MGB Biopharma Presents at INV€$TIVAL SHOWCASE 2019

News & Events

News

MGB Biopharma Announces Successful Outcome from Phase II Clinical Study with MGB-BP-3 – a Potential New Gold Standard, First-Line Treatment for Clostridium difficile Infection (CDI)

MGB Biopharma to Attend Upcoming BioEurope Meeting in Hamburg on 11 to 13 Nov 2019

MGB Biopharma Announces Promising Phase IIa Clinical Trial Update for MGB-BP-3

MGB Biopharma Announces Completion of Funding Round

Scottish Biopharmaceutical Company MGB Biopharma Receives £2.78m Grant Award For Phase IIa Clinical Trial

Join our mailing list